Publications by authors named "Stephen B Hanauer"

Claim this Profile
A
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease.
Jurij Hanžel, Virginia Solitano, Sudheer Kumar Vuyyuru, Remo Panaccione, Bruce E Sands, Stephen B Hanauer

Gastroenterology· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endoscopic Response to Subcutaneous Infliximab by Disease Location: A Post Hoc Analysis of the LIBERTY-CD Study.
Bruce E Sands, Stefan Schreiber, Marla C Dubinsky, Geert D'Haens, Bincy P Abraham, Stephen B Hanauer

Clin Gastroenterol Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Outcomes With Subcutaneous Infliximab (CT-P13 SC) by Baseline Immunosuppressant Use: A Post Hoc Analysis of the LIBERTY-CD and LIBERTY-UC Studies.
Stefan Schreiber, Jean-Frederic Colombel, Stephen B Hanauer, William J Sandborn, Silvio Danese

Inflamm Bowel Dis· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis.
Marc Ferrante, Laurent Peyrin-Biroulet, Perttu Arkkila, Alessandro Armuzzi, Jean-Frédéric Colombel, Stephen B Hanauer

Therap Adv Gastroenterol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The position of anti-tumor necrosis factor agents for the treatment of adult patients with Crohn's disease.
Stephen B Hanauer, Byong Duk Ye, Raymond K Cross, Silvio Danese, Geert D'Haens

Expert Rev Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Precision-Guided Dosing on Clinical Decision-Making and Health Care Utilization in Inflammatory Bowel Disease: A Retrospective Pretest/Posttest Real-World Study.
Ronen Arai, Adria Condino, Bincy P Abraham, Stephen B Hanauer, Udayakumar Navaneethan

Crohns Colitis 360· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous infliximab (CT-P13 SC) as maintenance therapy for Crohn's disease and ulcerative colitis: 2-year results from open-label extensions of two randomized controlled trials (LIBERTY).
Jean-Frederic Colombel, William J Sandborn, Stefan Schreiber, Silvio Danese, Maria Kłopocka, Stephen B Hanauer

J Crohns Colitis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn's Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis.
Bruce E Sands, Laurent Peyrin-Biroulet, Stefan Schreiber, Silvio Danese, Alessandro Armuzzi, Stephen B Hanauer

J Clin Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticosteroid Use in Randomized Clinical Trials of Biologics and Small Molecules in Inflammatory Bowel Disease: A Systematic Review.
Bruno César da Silva, Sam Papasotiriou, Stephen B Hanauer

Inflamm Bowel Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytomegalovirus Isolated to a Colon Polyp in a Patient with Ulcerative Colitis on Ozanimod: A Case Report.
Zehra Naseem, Ahmed Nadeem, Aidan J David, Aun Muhammad, Fatima Zehra Shah, Stephen B Hanauer

Case Rep Gastroenterol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Stephen B Hanauer, Bruce E Sands, Jean-Frédéric Colombel

Gastroenterology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic polymorphisms impacting clinical pharmacology of drugs used to treat inflammatory bowel disease: a precursor to multi-omics approach to precision medicine.
Matthew B Stanton, Mark A Solinski, Stephen B Hanauer

Expert Rev Clin Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tofacitinib Does Not Impair Sperm Quality in Men With Ulcerative Colitis.
Anne Grosen, Emanuelle Bellaguarda, Ingela Liljeqvist-Soltic, Anne-Bine Skytte, Stephen B Hanauer

Inflamm Bowel Dis· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply.
Stephen B Hanauer, Jean-Frederic Colombel

Gastroenterology· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Clinical Utility of Precision-Guided Dosing for Adalimumab Therapy Optimization in Inflammatory Bowel Disease: A Clinical Experience Program.
Stephen B Hanauer, Esther A Torres, Patricia Aragon-Han, Jonathon C Chapman, Arun C Swaminath

Pharmaceutics· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of immunogenicity in optimizing biological therapies for inflammatory bowel disease.
Konika Sharma, Bruno César da Silva, Stephen B Hanauer

Expert Rev Gastroenterol Hepatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT-UC Consortium.
Parambir S Dulai, Lauren Balmert Bonner, Charlotte Sadler, Laura E Raffals, Gursimran Kochhar, Stephen B Hanauer

Aliment Pharmacol Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Disease Severity Index for Inflammatory Bowel Disease Is a Valid Instrument that Predicts Complicated Disease.
Akhilesh Swaminathan, James M Fulforth, Chris M Frampton, Grace M Borichevsky, Thomas C Mules, Stephen B Hanauer

Inflamm Bowel Dis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adaptive Steroid Tapering Impedes Corticosteroid-free Remissions Compared with Forced Tapering in Clinical Trials of Ulcerative Colitis.
Neeraj Narula, Hasan Hamam, Jasmine Liu, Emily C L Wong, John K Marshall, Stephen B Hanauer

J Crohns Colitis· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of immune checkpoint inhibitor-related gastrointestinal, hepatobiliary, and pancreatic adverse events.
Malek Shatila, Hao Chi Zhang, Anusha Shirwaikar Thomas, Antonio Pizuorno Machado, Sidra Naz, Stephen B Hanauer

J Immunother Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Inflammatory Bowel Disease: Two Randomized Phase 3 Trials (LIBERTY).
Stephen B Hanauer, Bruce E Sands, Stefan Schreiber, Silvio Danese, Maria Kłopocka

Gastroenterology· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EXPLORing the Therapeutic Ceiling in Crohn's Disease: Will Combination Pave the Way?
Joana Torres, Stephen B Hanauer

Clin Gastroenterol Hepatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue-specific reprogramming leads to angiogenic neutrophil specialization and tumor vascularization in colorectal cancer.
Triet M Bui, Lenore K Yalom, Edward Ning, Jessica M Urbanczyk, Xingsheng Ren, Stephen B Hanauer

J Clin Invest· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review of Adalimumab Biosimilar SB5 in Immune-Mediated Inflammatory Diseases.
Jonathan Kay, Raymond K Cross, Steven R Feldman, Younjin Park, Stephen B Hanauer

Adv Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Highlights in Ulcerative Colitis From Digestive Disease Week 2023: Commentary.
Stephen B Hanauer

Gastroenterol Hepatol (N Y)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis